Get started
Author

Christopher Alan Muir

Observed names: C A Muir, C. Muir, C.A. Muir, CHRISTOPHER A. MUIR, Christopher A Muir, Christopher A. Muir, Christopher Muir, Muir, Christopher
Observed institutions: The University of Sydney, Concord Hospital, Memorial University of Newfoundland, Garvan Institute of Medical Research, Royal Prince Alfred Hospital, Concord Repatriation General Hospital, Monash Medical Centre, Princess Alexandra Hospital, Blacktown & Mount Druitt Hospital, UNSW Sydney, St Vincent's Hospital Sydney, The George Institute for Global Health, Centre for Big Data Research in Health, Monash University, Western Sydney University
ORCID: 0000-0002-1430-0499
Observed ORCID: 0000-0002-1430-0499
OpenAlex ID: A5000616423
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
2023 · Stephan Petersenn, Maria Fleseriu, et al. · Nature Reviews Endocrinology · 401
PDF
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment
2021 · Christopher A Muir, Roderick J Clifton-Bligh, et al. · The Journal of Clinical Endocrinology & Metabolism · 212
Buttonhole Cannulation and Clinical Outcomes in a Home Hemodialysis Cohort and Systematic Review
2013 · Christopher A. Muir, Sradha S. Kotwal, et al. · Clinical Journal of the American Society of Nephrology · 120
Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress
2007 · R. Adamec, C. Muir, et al. · Behavioural Brain Research · 117
Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer
2020 · Christopher A. Muir, Alexander M. Menzies, et al. · Thyroid · 78
Association of Antithyroid Antibodies in Checkpoint Inhibitor–Associated Thyroid Immune–Related Adverse Events
2022 · Christopher A Muir, Cameron C G Wood, et al. · The Journal of Clinical Endocrinology & Metabolism · 57
PDF
Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
2019 · Matthew G. Cehic, Christopher A. Muir, et al. · Transplantation Direct · 56
Immune Related Adverse Events of the Thyroid – A Narrative Review
2022 · Christopher A. Muir, Venessa H. M. Tsang, et al. · Frontiers in Endocrinology · 54
PDF
Empagliflozin in the management of diabetes mellitus after cardiac transplantation
2017 · Christopher A. Muir, Jerry R. Greenfield, et al. · The Journal of Heart and Lung Transplantation · 39
Predicting Weight Gain in Patients Treated With Clozapine
2016 · Sue Lynn Lau, Christopher Muir, et al. · Journal of Clinical Psychopharmacology · 30
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity
2025 · Christopher A Muir, Gary A Wittert, et al. · The Journal of Clinical Endocrinology & Metabolism · 22
Sodium glucose cotransporter 2 inhibitor‐induced ketoacidosis is unlikely in patients without diabetes
2023 · Lisa M Raven, Christopher A Muir, et al. · The Medical Journal of Australia · 17
PDF
Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment
2021 · Lisa M. Raven, Michelle Guttman-Jones, et al. · Endocrine · 15
Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial
2023 · Lisa Mary Raven, Christopher A Muir, et al. · BMJ Open · 14
PDF
Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes
2025 · Carlota Arenillas, Lucía Celada, et al. · Cancer Discovery · 13
Association of early post‐transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation
2024 · Christopher A. Muir, William Kuang, et al. · Diabetic Medicine · 12
PDF
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
2023 · Stephan Petersenn, Maria Fleseriu, et al. · Nature Reviews Endocrinology · 10
PDF
Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease
2020 · Christopher A. Muir, Graham R.D. Jones, et al. · Endocrine Practice · 10
Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation
2025 · Lisa M. Raven, Jerry R. Greenfield, et al. · JHLT Open · 8
PDF
Efficacy of Gonadotropin Treatment for Induction of Spermatogenesis in Men With Pathologic Gonadotropin Deficiency: A Meta‐Analysis
2024 · Christopher A. Muir, Ting Zhang, et al. · Clinical Endocrinology · 8
Testosterone and Erythrocyte Lifespan
2024 · Melissa C McMartin, Sasha Savkovic, et al. · The Journal of Clinical Endocrinology & Metabolism · 8
Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients
2024 · Lisa M Raven, Louise Goodall, et al. · JCEM Case Reports · 6
PDF
Early post-transplant hyperglycemia and post-transplant diabetes mellitus following heart transplantation
2024 · William Kuang, Lisa M. Raven, et al. · Expert Review of Endocrinology & Metabolism · 6
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists
2022 · Lisa M. Raven, Christopher A. Muir, et al. · Acta Diabetologica · 6
Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation
2020 · Phillip Lo, Katherine Kearney, et al. · AACE Clinical Case Reports · 6
Works count: 65
Citation count: 1,361
H-index: 14
I10-index: 18
Year
Topic
Type